{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:35:36Z","timestamp":1758274536628,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04691-0","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:02:21Z","timestamp":1723939341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Chie","family":"Asou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodai","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itoko","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Kakegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Terui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-8453","authenticated-orcid":false,"given":"Yuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,18]]},"reference":[{"key":"4691_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","volume":"1","author":"A Tefferi","year":"2015","unstructured":"Tefferi A, Pardanani A. Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 2015;1:97\u2013105.","journal-title":"JAMA Oncol"},{"key":"4691_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.95","volume":"5","author":"S Cerquozzi","year":"2015","unstructured":"Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015;5: e366. https:\/\/doi.org\/10.1038\/bcj.2015.95.","journal-title":"Blood Cancer J"},{"key":"4691_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.2019000943","volume":"136","author":"AJ Dunbar","year":"2020","unstructured":"Dunbar AJ, Rampal RK, Levine R. Leukemia secondary to myeloproliferative neoplasms. Blood. 2020;136:61\u201370.","journal-title":"Blood"},{"key":"4691_CR4","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1182\/bloodadvances.2020002271","volume":"4","author":"D Luque Paz","year":"2020","unstructured":"Luque Paz D, Jouanneau-Courville R, Riou J, et\u00a0al. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time of transformation. Blood Adv. 2020;4:4887\u201397.","journal-title":"Blood Adv"},{"key":"4691_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41408-023-00878-8","volume":"13","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Alkhateeb H, Gangat M. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm. Blood Cancer J. 2023;13:108. https:\/\/doi.org\/10.1038\/s41408-023-00878-8.","journal-title":"Blood Cancer J"},{"key":"4691_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.leu.2401340","volume":"13","author":"M Batlle","year":"1999","unstructured":"Batlle M, Fern\u00e1ndez-Avil\u00e9s F, Ribera JM, et\u00a0al. Acute promyelocytic leukemia in a patient with idiopatic myelofibrosis. Leukemia. 1999;13:492\u20134.","journal-title":"Leukemia"},{"key":"4691_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/sj.leu.2401358","volume":"13","author":"PN Mollee","year":"1999","unstructured":"Mollee PN, Taylor KM, Williams B, et\u00a0al. Long-term molecular remission in promyelocytic transformation of myeloproliferative disease. Leukemia. 1999;13:648\u201350.","journal-title":"Leukemia"},{"key":"4691_CR8","first-page":"520","volume":"72","author":"T Kajiguchi","year":"2000","unstructured":"Kajiguchi T, Simokawa T, Saito M, et\u00a0al. Transformation of polycythemia vera to acute promyelocytic leukemia. Int J Hematol. 2000;72:520\u20131.","journal-title":"Int J Hematol"},{"key":"4691_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ajh.10195","volume":"71","author":"N Sato","year":"2002","unstructured":"Sato N, Furukawa T, Masuko M, et\u00a0al. Acute promyelocytic leukemia developing in untreated essential thrombocythemia. Am J Hematol. 2002;71:114\u20136.","journal-title":"Am J Hematol"},{"key":"4691_CR10","first-page":"8","volume":"4","author":"TP Braun","year":"2015","unstructured":"Braun TP, Maxson JE, Agarwal A, et\u00a0al. Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome. Leuk Res Rep. 2015;4:8\u201311.","journal-title":"Leuk Res Rep"},{"key":"4691_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/sci.2016.03.02","volume":"3","author":"A Mamorska-Dyga","year":"2016","unstructured":"Mamorska-Dyga A, Wu J, Khattar P, et\u00a0al. Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report. Stem Cell Investig. 2016;3:8.","journal-title":"Stem Cell Investig"},{"key":"4691_CR12","volume":"15","author":"E Morsia","year":"2021","unstructured":"Morsia E, Goteri G, Torre E, et\u00a0al. Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia-myelofibrosis with splanchnic vein thrombosis: a case report. Leuk Res Rep. 2021;15: 100243.","journal-title":"Leuk Res Rep"},{"key":"4691_CR13","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.2147\/OTT.S208290","volume":"12","author":"K Nadiminti","year":"2019","unstructured":"Nadiminti K, Silverman M, Bhagavathi S, et\u00a0al. t(15;17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma. Onco Targets Ther. 2019;12:5449\u201355.","journal-title":"Onco Targets Ther"},{"key":"4691_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030064","volume":"101","author":"W-W Li","year":"2022","unstructured":"Li W-W, Sui X-F, Fun S, et\u00a0al. Transformation from polycythemia vera to acute promyelocytic leukemia: case report and literature review. Medicine. 2022;101: e30064. https:\/\/doi.org\/10.1097\/MD.0000000000030064.","journal-title":"Medicine"},{"key":"4691_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-023-05112-w","volume":"102","author":"R Zhang","year":"2023","unstructured":"Zhang R, Liu R, Song H, et\u00a0al. Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia. Ann Hematol. 2023;102:981\u20134.","journal-title":"Ann Hematol"},{"key":"4691_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ajh.2830300408","volume":"30","author":"E Knottenbelt","year":"1989","unstructured":"Knottenbelt E, Hallett J, Jacobs P. 8;21 translocation in myelodysplasia secondary to essential thrombocythemia. Am J Hematol. 1989;30:233\u20135.","journal-title":"Am J Hematol"},{"key":"4691_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ajh.26186","volume":"96","author":"N Gangat","year":"2021","unstructured":"Gangat N, Guglielmelli P, Szuber N, et\u00a0al. Venetoclax with azacytidine or decitabine in blast-phase myeloproliferative neoplasm: a multicenter series of 32 consecutive case. Am J Hematol. 2021;96:781\u20139.","journal-title":"Am J Hematol"},{"key":"4691_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/leu.2014.4","volume":"28","author":"M-T Krauth","year":"2014","unstructured":"Krauth M-T, Eder C, Alpermann T, et\u00a0al. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)\/RUNX1-RUNX1T1: frequency and impact on clinical outcome. Leukemia. 2014;28:1449\u201358.","journal-title":"Leukemia"},{"key":"4691_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.13283","volume":"94","author":"E Iwanaga","year":"2009","unstructured":"Iwanaga E, Nanri T, Matsuno N, Kawakita T, Mitsuya H, Asou N. A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia. Haematologica. 2009;94:433\u20135.","journal-title":"Haematologica"},{"key":"4691_CR20","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1182\/blood-2018-05-852822","volume":"133","author":"F Christen","year":"2019","unstructured":"Christen F, Hoyer K, Yoshida K, et\u00a0al. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. Blood. 2019;133:1140\u201351.","journal-title":"Blood"},{"key":"4691_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0165-4608(92)90143-V","volume":"58","author":"MT Ferro","year":"1992","unstructured":"Ferro MT, Steegman JL, Escribano L, et\u00a0al. Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis. Cancer Genet Cytogenet. 1992;58:96\u20139.","journal-title":"Cancer Genet Cytogenet"},{"key":"4691_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1046\/j.1365-2141.1999.01588.x","volume":"106","author":"K Kojima","year":"1999","unstructured":"Kojima K, Yasukawa M, Ishimaru F, et\u00a0al. Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase. Br J Haematol. 1999;106:720\u20132.","journal-title":"Br J Haematol"},{"key":"4691_CR23","first-page":"1811","volume":"12","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu X, et\u00a0al. Co-existence of t(9;22) and t(8;21) in primary blast phase of chronic myelogenous leukemia: clinical experience and literature review. Int J Clin Exp Pathol. 2019;12:1811\u20135.","journal-title":"Int J Clin Exp Pathol"},{"key":"4691_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520919237","author":"C-C Ma","year":"2020","unstructured":"Ma C-C, Chai Y, Chen HL, et\u00a0al. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia. J Int Med Res. 2020. https:\/\/doi.org\/10.1177\/0300060520919237.","journal-title":"J Int Med Res"},{"key":"4691_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13039-020-00501-6","volume":"13","author":"J-Y Gong","year":"2020","unstructured":"Gong J-Y, Zhang Z-H, Zhang W, et\u00a0al. Coexistence of recurrent chromosomal abnormalities and the Philadelphia chromosome in acute and chronic myeloid leukemias: report of five cases and review of literature. Mol Cytogenet. 2020;13:34\u201342.","journal-title":"Mol Cytogenet"},{"key":"4691_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.clml.2020.12.025","volume":"21","author":"K Morita","year":"2021","unstructured":"Morita K, Jabbour E, Ravandi F, et\u00a0al. Clinical outcomes of patients with concurrent core binding factor rearrangement and Philadelphia chromosome. Clin Lymphoma Myeloma Leuk. 2021;21:338\u201344.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4691_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-0609.2008.01163.x","volume":"82","author":"K Abdulkarim","year":"2009","unstructured":"Abdulkarim K, Girodon F, Johansson P, et\u00a0al. AML transformation in 56 patients with Ph- MPD in two well defined populations. Eur J Haematol. 2009;82:106\u201311.","journal-title":"Eur J Haematol"},{"key":"4691_CR28","first-page":"130","volume-title":"World Health organization classification of tumours of haematopoietic and lymphoid tissues","author":"DA Arber","year":"2017","unstructured":"Arber DA, Porwit A, Brunning RD, et\u00a0al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swedlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors., et\u00a0al., World Health organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: Lyon IARC Press; 2017. p. 130\u201349.","edition":"4"},{"key":"4691_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/bloodadvances.2022008259","volume":"7","author":"R Wang","year":"2023","unstructured":"Wang R, Shallis RM, Stempel JM, et\u00a0al. Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea. Blood Adv. 2023;7:734\u201343.","journal-title":"Blood Adv"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04691-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:02:31Z","timestamp":1723939351000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04691-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04691-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2024,8,18]]},"assertion":[{"value":"9 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed with prior approval of the Institutional Review Board and the Ethics Committee of the Saitama Medical University Hospital (the committee\u2019s reference number: 12-089). Written informed consent for the study was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}